UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review

Health and quality of life outcomes, 2018-12, Vol.16 (1), p.228-228, Article 228

2018

Link zum Volltext

Verfügbarkeit prüfen

Patient-reported outcomes in randomised clinical trials of bladder cancer: an updated systematic review

BMC urology, 2019-09, Vol.19 (1), p.86-86, Article 86

2019

Link zum Volltext

Verfügbarkeit prüfen

Harnessing the patient voice in prostate cancer research: Systematic review on the use of patient‐reported outcomes in randomized controlled trials to support clinical decision‐making

Cancer medicine (Malden, MA), 2020-06, Vol.9 (12), p.4039-4058

2020

Link zum Volltext

Verfügbarkeit prüfen

Raising the standards of patient‐centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS‐RIGHT project

Cancer medicine (Malden, MA), 2023-03, Vol.12 (6), p.7529-7539

2023

Link zum Volltext

Verfügbarkeit prüfen

Pushing the Boundaries of Care in Myelodysplastic Syndromes: Physical Exercise to Improve Fatigue and Health-Related Quality of Life Outcomes

Leukemia research, 2016-10, Vol.49, p.36-37

2016

Link zum Volltext

Verfügbarkeit prüfen

Physicians' Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform

Frontiers in oncology, 2022-03, Vol.12, p.826040-826040

2022

Link zum Volltext

Verfügbarkeit prüfen

A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol

Health and quality of life outcomes, 2018-06, Vol.16 (1), p.127-127, Article 127

2018

Link zum Volltext

Verfügbarkeit prüfen

High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity

International journal of hematology, 2020-08, Vol.112 (2), p.141-146

2020

Link zum Volltext

Verfügbarkeit prüfen

Physicians' attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients

Health and quality of life outcomes, 2017-10, Vol.15 (1), p.204-204, Article 204

2017

Link zum Volltext

Verfügbarkeit prüfen

Time for patient reported outcomes assessment in routine hematology practice: the case of chronic myeloid leukemia

Expert review of hematology, 2019-01, Vol.12 (1), p.1-3

2019

Link zum Volltext

Verfügbarkeit prüfen

Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-Analysis

Value in health, 2021-02, Vol.24 (2), p.250-267

2021

Link zum Volltext

Verfügbarkeit prüfen

Patient-Reported Outcomes in Randomized Controlled Trials of Patients with Multiple Myeloma: A Systematic Literature Review of Studies Published Between 2014 and 2021

Clinical lymphoma, myeloma and leukemia, 2022-07, Vol.22 (7), p.442-459

2022

Link zum Volltext

Verfügbarkeit prüfen

Reply to M. Koehler et al

Journal of clinical oncology, 2015-03, Vol.33 (9), p.1091-1092

2015

Link zum Volltext

Verfügbarkeit prüfen

Investigating Trends in the Quality of Reporting of Patient-Reported Outcomes in Oncology Over Time: Analysis of 631 Randomized Controlled Trials Published Between 2004 and 2019

Value in health, 2021-12, Vol.24 (12), p.1715-1719

2021

Link zum Volltext

Verfügbarkeit prüfen

Propensity score methods and regression adjustment for analysis of nonrandomized studies with health‐related quality of life outcomes

Pharmacoepidemiology and drug safety, 2019-05, Vol.28 (5), p.690-699

2019

Link zum Volltext

Verfügbarkeit prüfen

The estimand framework had implications in time to patient-reported outcomes deterioration analyses in cancer clinical trials

Journal of clinical epidemiology, 2023-10, Vol.162, p.118-126

2023

Link zum Volltext

Verfügbarkeit prüfen

The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3L

Journal of clinical epidemiology, 2021-09, Vol.137, p.31-44

2021

Link zum Volltext

Verfügbarkeit prüfen

The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial

Annals of hematology, 2023-04, Vol.102 (4), p.927-935

2023

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial

The lancet oncology, 2024-05, Vol.25 (5), p.614-625

2024

Link zum Volltext

Verfügbarkeit prüfen

Time to improve health-related quality of life outcomes in patients with acute promyelocytic leukemia

Blood, 2015-11, Vol.126 (22), p.2523-2524

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes

Journal of clinical oncology, 2014-10, Vol.32 (30), p.3406-3412

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

PublikationsformBerichte

ThemaQuality Of Life

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(53)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review

Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

Patient-reported outcomes in randomised clinical trials of bladder cancer: an updated systematic review

Harnessing the patient voice in prostate cancer research: Systematic review on the use of patient‐reported outcomes in randomized controlled trials to support clinical decision‐making

Raising the standards of patient‐centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS‐RIGHT project

Pushing the Boundaries of Care in Myelodysplastic Syndromes: Physical Exercise to Improve Fatigue and Health-Related Quality of Life Outcomes

Physicians' Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform

A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol

High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity

Physicians' attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients

Time for patient reported outcomes assessment in routine hematology practice: the case of chronic myeloid leukemia

Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-Analysis

Patient-Reported Outcomes in Randomized Controlled Trials of Patients with Multiple Myeloma: A Systematic Literature Review of Studies Published Between 2014 and 2021

Reply to M. Koehler et al

Investigating Trends in the Quality of Reporting of Patient-Reported Outcomes in Oncology Over Time: Analysis of 631 Randomized Controlled Trials Published Between 2004 and 2019

Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

Propensity score methods and regression adjustment for analysis of nonrandomized studies with health‐related quality of life outcomes

The estimand framework had implications in time to patient-reported outcomes deterioration analyses in cancer clinical trials

Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia

The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3L

The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial

Patient‐reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia

Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial

Time to improve health-related quality of life outcomes in patients with acute promyelocytic leukemia

Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes

Aktive Filter

Suchergebnisse filtern